1.07
+0.02(+1.90%)
Currency In USD
| Previous Close | 1.05 |
| Open | 1.06 |
| Day High | 1.09 |
| Day Low | 1.04 |
| 52-Week High | 3.26 |
| 52-Week Low | 1.02 |
| Volume | 157,111 |
| Average Volume | 1.52M |
| Market Cap | 10.97M |
| PE | -0.86 |
| EPS | -1.24 |
| Moving Average 50 Days | 1.4 |
| Moving Average 200 Days | 1.61 |
| Change | 0.02 |
If you invested $1000 in Cocrystal Pharma, Inc. (COCP) 10 years ago, it would be worth $3.81 as of October 17, 2025 at a share price of $1.07. Whereas If you bought $1000 worth of Cocrystal Pharma, Inc. (COCP) shares 5 years ago, it would be worth $99.07 as of October 17, 2025 at a share price of $1.07.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
GlobeNewswire Inc.
Oct 02, 2025 12:00 PM GMT
BOTHELL, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the Noble Capital Markets Emerging Growth Virtual
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Sep 15, 2025 8:30 PM GMT
$4.7 million upfront with up to an additional approximately $8.3 million of potential aggregate gross proceeds upon the exercise in full of warrants BOTHELL, Wash., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc., (Nasdaq: COCP) (the “Com
Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Sep 12, 2025 1:43 PM GMT
$4.7 million upfront with up to an additional approximately $8.3 million of potential aggregate gross proceeds upon the exercise in full of warrants BOTHELL, Wash., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc., (Nasdaq: COCP) (the “Com